Prostatis Group Portfolio holdings
Top Buys
| 1 |
State Street SPDR S&P 1500 Value Tilt ETF
VLU
|
+$6.27M |
| 2 |
Vanguard Growth ETF
VUG
|
+$4.75M |
| 3 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$2.1M |
| 4 |
iShares ESG Optimized MSCI USA ETF
SUSA
|
+$1.97M |
| 5 |
iShares MSCI KLD 400 Social ETF
DSI
|
+$1.96M |
Top Sells
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.61M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.96M |
| 3 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$2.51M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.22M |
| 5 |
iShares MSCI EAFE Min Vol Factor ETF
EFAV
|
+$2.22M |
Sector Composition
| 1 | Technology | 5.73% |
| 2 | Healthcare | 3.27% |
| 3 | Communication Services | 2.86% |
| 4 | Consumer Discretionary | 2% |
| 5 | Financials | 1.63% |
Similar funds
Prostatis Group's Q2 2021 Portfolio in Review
As of Q2 2021, Prostatis Group held 110 positions worth $146M, up 15% from $127M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Prostatis Group deployed $11.2M of net new capital in Q2 2021, opening 15 new positions and adding to 41 existing holdings. Its largest new stake was State Street SPDR S&P 1500 Value Tilt ETF: 43,082 shares worth $6.31M.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.6% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $5.61M trimmed.
- Prostatis Group's largest Q2 2021 buy was State Street SPDR S&P 1500 Value Tilt ETF: 43,082 shares worth $6.31M.
- Prostatis Group added most to Vanguard Growth ETF in Q2 2021, an estimated $4.75M increase.
- Prostatis Group's biggest Q2 2021 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $5.61M.
- Prostatis Group fully exited iShares Global Clean Energy ETF in Q2 2021, selling an estimated $1.55M.
- Prostatis Group's ten largest holdings make up 44% of its $146M portfolio in Q2 2021.
- Prostatis Group opened 15 new positions and closed 9 in Q2 2021.
- Prostatis Group's portfolio value rose 15% quarter-over-quarter to $146M.
Based on Prostatis Group's 13F filing for Q2 2021, filed 23 Mar 2023.